Algorithms for systemic therapy of prostate cancer, transitional cell carcinoma and renal cell carcinoma

被引：0
|
作者：
Eisenhardt, A. [1 ,2 ]
Ohlmann, C-H [3 ]
Doehn, C. [4 ,5 ]
机构：
[1] Praxiskliniken Urol Rhein Ruhr, Schulstr 11, D-45468 Mulheim, Germany
[2] Univ Klinikum Essen, Klin & Poliklin Urol Kinderurol & Uroonkol, Essen, Germany
[3] Malteser Krankenhaus Seliger Gerhard Bonn, Klin Urol, Bonn, Germany
[4] Urologikum Lubeck, Lubeck, Germany
[5] Deutsch Uroonkologen D Uo, Berlin, Germany
来源：
UROLOGE | 2020年 / 59卷 / 05期
关键词：
Androgene deprivation; Combination therapy; Drug-related side effects; Chemotherapy; Hormone suppression; METASTATIC UROTHELIAL CARCINOMA; CISPLATIN-INELIGIBLE PATIENTS; PHASE-III TRIAL; PLUS PREDNISONE; SINGLE-ARM; ANDROGEN-DEPRIVATION; VINFLUNINE PLUS; SUPPORTIVE CARE; SURVIVAL; MULTICENTER;
D O I：
10.1007/s00120-020-01182-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Systemic therapy in uro-oncology is currently undergoing major changes. In the past, drug therapies only showed good treatment results in metastasized testicular tumors. New developments indicate that an improved understanding of tumor biology will lead to targeted treatment strategies for metastatic prostate, urothelial and renal cell carcinoma. In the following article, we summarize the practice-relevant innovations in systemic therapy in the guidelines on prostate cancer, transitional cell carcinoma of the bladder and renal cell carcinoma.
引用
收藏
页码：533 / 542
页数：10
相关论文
共 50 条
  • [1] Algorithmen zur Systemtherapie bei Prostata‑, Urothel- und NierenzellkarzinomAlgorithms for systemic therapy of prostate cancer, transitional cell carcinoma and renal cell carcinoma
    A. Eisenhardt
    C.-H. Ohlmann
    C. Doehn
    Der Urologe, 2020, 59 : 533 - 543
  • [2] A kidney carcinoma with features of clear cell renal carcinoma and transitional cell carcinoma: a combined renal cell and transitional cell carcinoma?
    Terada, T
    Inatsuchi, H
    Yasuda, M
    Osamura, Y
    VIRCHOWS ARCHIV, 2003, 443 (04) : 583 - 585
  • [3] A kidney carcinoma with features of clear cell renal carcinoma and transitional cell carcinoma: a combined renal cell and transitional cell carcinoma?
    Tadashi Terada
    Hiroaki Inatsuchi
    Masanori Yasuda
    Yoshiyuki Osamura
    Virchows Archiv, 2003, 443 : 583 - 585
  • [4] Systemic therapy of renal cell carcinoma
    Gruenwald, Viktor
    Ravaud, Alain
    WORLD JOURNAL OF UROLOGY, 2014, 32 (01) : 1 - 1
  • [5] Systemic therapy of renal cell carcinoma
    Viktor Grünwald
    Alain Ravaud
    World Journal of Urology, 2014, 32 : 1 - 1
  • [6] Systemic therapy for renal cell carcinoma
    Motzer, RJ
    Russo, P
    JOURNAL OF UROLOGY, 2000, 163 (02): : 408 - 417
  • [7] TRANSITIONAL CELL-CARCINOMA OF THE PROSTATE FOLLOWING INTRAVESICAL THERAPY FOR TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    HARDEMAN, SW
    PERRY, A
    SOLOWAY, MS
    JOURNAL OF UROLOGY, 1988, 140 (02): : 289 - 292
  • [8] Systemic therapy of renal cell carcinoma
    Staehler, M.
    Tuellmann, C.
    Nuhn, P.
    Haseke, N.
    Stief, C. G.
    UROLOGE, 2010, 49 (12): : 1543 - 1550
  • [9] TRANSITIONAL CELL CARCINOMA OF PROSTATE
    RUBENSTEIN, AB
    RUBNITZ, ME
    CANCER, 1969, 24 (03) : 543 - +
  • [10] Transitional cell carcinoma of the prostate
    Bassi, P. F.
    Falabella, R.
    Pinto, F.
    Sacco, E.
    Racioppi, M.
    UROLOGIA JOURNAL, 2007, 74 (01) : 15 - 21
12345